Trial Outcomes & Findings for Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia (NCT NCT05124704)

NCT ID: NCT05124704

Last Updated: 2025-01-09

Results Overview

Recording propofol EC50 for inducing loss of conciousness between general with epidural anesthesia group and general group with propofol effect-site target-controlled infusion (TCI) system

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

60 participants

Primary outcome timeframe

From anesthesia induction to patient loss of consciousness, an average of 5 minutes.

Results posted on

2025-01-09

Participant Flow

Participant milestones

Participant milestones
Measure
Combined Epidural With General Anesthesia
Patients in this group received 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction.Followed by a continuous infusion of 4-6 ml 0.375% ropivacaine was applied using micro-infusion pump after induction during surgery. 5-8ml 0.375% ropivacaine: 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction in experimental group. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
General Anesthesia
In this group, same dose of normal saline was administered before induction and during surgery. 5-8ml normal saline: 5-8ml of normal saline depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
Overall Study
STARTED
30
30
Overall Study
COMPLETED
30
30
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Combined Epidural With General Anesthesia
n=30 Participants
Patients in this group received 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction.Followed by a continuous infusion of 4-6 ml 0.375% ropivacaine was applied using micro-infusion pump after induction during surgery. 5-8ml 0.375% ropivacaine: 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction in experimental group. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
General Anesthesia
n=30 Participants
In this group, same dose of normal saline was administered before induction and during surgery. 5-8ml normal saline: 5-8ml of normal saline depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
Total
n=60 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
18 Participants
n=5 Participants
21 Participants
n=7 Participants
39 Participants
n=5 Participants
Age, Categorical
>=65 years
12 Participants
n=5 Participants
9 Participants
n=7 Participants
21 Participants
n=5 Participants
Age, Continuous
59.5 years
n=5 Participants
62 years
n=7 Participants
60.5 years
n=5 Participants
Sex: Female, Male
Female
14 Participants
n=5 Participants
9 Participants
n=7 Participants
23 Participants
n=5 Participants
Sex: Female, Male
Male
16 Participants
n=5 Participants
21 Participants
n=7 Participants
37 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
30 Participants
n=5 Participants
30 Participants
n=7 Participants
60 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
China
30 participants
n=5 Participants
30 participants
n=7 Participants
60 participants
n=5 Participants

PRIMARY outcome

Timeframe: From anesthesia induction to patient loss of consciousness, an average of 5 minutes.

Recording propofol EC50 for inducing loss of conciousness between general with epidural anesthesia group and general group with propofol effect-site target-controlled infusion (TCI) system

Outcome measures

Outcome measures
Measure
Combined Epidural With General Anesthesia
n=30 Participants
Patients in this group received 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction.Followed by a continuous infusion of 4-6 ml 0.375% ropivacaine was applied using micro-infusion pump after induction during surgery. 5-8ml 0.375% ropivacaine: 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction in experimental group. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
General Anesthesia
n=30 Participants
In this group, same dose of normal saline was administered before induction and during surgery. 5-8ml normal saline: 5-8ml of normal saline depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
Propofol EC50 for Inducing Loss of Conciousness
2.97 ug/ml
Standard Deviation 0.44
3.36 ug/ml
Standard Deviation 0.22

PRIMARY outcome

Timeframe: From anesthesia induction to the patient loss of consciousness, an average of 5 minutes.

Recording the effect-site concentration of propofol (Ceprop) which showed on target-controlled infusion (TCI) system at loss of consciousness and discontinuation of anesthetics

Outcome measures

Outcome measures
Measure
Combined Epidural With General Anesthesia
n=30 Participants
Patients in this group received 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction.Followed by a continuous infusion of 4-6 ml 0.375% ropivacaine was applied using micro-infusion pump after induction during surgery. 5-8ml 0.375% ropivacaine: 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction in experimental group. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
General Anesthesia
n=30 Participants
In this group, same dose of normal saline was administered before induction and during surgery. 5-8ml normal saline: 5-8ml of normal saline depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
Predicted Effect-site Concentration of Propofol (Ceprop) at Certain Time Points
2.63 ug/ml
Standard Deviation 0.38
1.97 ug/ml
Standard Deviation 0.56

SECONDARY outcome

Timeframe: From anesthesia induction to the end of surgery, an average of 2.5 hours.

Recording the total propofol and reminfentanil consumption during surgery

Outcome measures

Outcome measures
Measure
Combined Epidural With General Anesthesia
n=30 Participants
Patients in this group received 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction.Followed by a continuous infusion of 4-6 ml 0.375% ropivacaine was applied using micro-infusion pump after induction during surgery. 5-8ml 0.375% ropivacaine: 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction in experimental group. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
General Anesthesia
n=30 Participants
In this group, same dose of normal saline was administered before induction and during surgery. 5-8ml normal saline: 5-8ml of normal saline depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
Anesthetics Consumption
0.11 Propofol (mg/Kg.min)
Standard Deviation 0.02
0.13 Propofol (mg/Kg.min)
Standard Deviation 0.02

SECONDARY outcome

Timeframe: 0-14 days postoperatively

Recording the first postoperative exhaust time by daily follow up

Outcome measures

Outcome measures
Measure
Combined Epidural With General Anesthesia
n=30 Participants
Patients in this group received 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction.Followed by a continuous infusion of 4-6 ml 0.375% ropivacaine was applied using micro-infusion pump after induction during surgery. 5-8ml 0.375% ropivacaine: 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction in experimental group. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
General Anesthesia
n=30 Participants
In this group, same dose of normal saline was administered before induction and during surgery. 5-8ml normal saline: 5-8ml of normal saline depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
Postoperative Exhaust Time
78.0 hours
Interval 58.5 to 110.0
85.0 hours
Interval 76.5 to 104.3

Adverse Events

Combined Epidural With General Anesthesia

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

General Anesthesia

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jiangling Wang

Zhejiang Cancer Hospital

Phone: 15168373331

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place